BlossomHill Therapeutics is a privately held, clinical-stage biopharmaceutical company headquartered in San Diego, California, founded in 2020 by drug designer J. Jean Cui, Ph.D. and biotech operator Y. Peter Li, Ph.D., M.B.A. It develops intelligently designed small-molecule medicines for oncology and autoimmune disease, led by BH-30643, a first-in-class macrocyclic non-covalent mutant-selective OMNI-EGFR inhibitor for EGFR- and HER2-mutated non-small cell lung cancer, and BH-30236, a macrocyclic CLK inhibitor for relapsed or refractory acute myeloid leukemia and higher-risk myelodysplastic syndrome. The company is a drug discovery business, not a software vendor: it publishes no public API, SDK, developer portal or machine-readable specification.
BlossomHill Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Drug Discovery.
BlossomHill Therapeutics’ developer surface includes engineering blog and 16 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/blossomhill-therapeutics/"><img src="https://apis.io/badge/blossomhill-therapeutics/card.svg" alt="BlossomHill Therapeutics on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
Stable Error Semantics+8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
13 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
aid: blossomhill-therapeutics
name: BlossomHill Therapeutics
description: 'BlossomHill Therapeutics is a privately held, clinical-stage biopharmaceutical company headquartered in San
Diego, California, founded in 2020 by drug designer J. Jean Cui, Ph.D. and biotech operator Y. Peter Li, Ph.D., M.B.A. It
develops intelligently designed small-molecule medicines for oncology and autoimmune disease, led by BH-30643, a first-in-class
macrocyclic non-covalent mutant-selective OMNI-EGFR inhibitor for EGFR- and HER2-mutated non-small cell lung cancer, and
BH-30236, a macrocyclic CLK inhibitor for relapsed or refractory acute myeloid leukemia and higher-risk myelodysplastic
syndrome. The company is a drug discovery business, not a software vendor: it publishes no public API, SDK, developer portal
or machine-readable specification.'
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: false
label: Hosted service · you call their endpoint
confidence: medium
source:
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
probe_state: none
source:
- security
generated: '2026-11-06'
method: derived
image: https://bhtherapeutics.com/wp-content/uploads/logo-stacked.svg
url: https://raw.githubusercontent.com/api-evangelist/blossomhill-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-07'
modified: '2026-08-07'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Drug Discovery
- Clinical Trials
- Life Sciences
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/blossomhill-therapeutics-domain-security.yml
- type: Website
url: https://bhtherapeutics.com/
- type: About
url: https://bhtherapeutics.com/about-us/
- type: Pipeline
url: https://bhtherapeutics.com/pipeline/
- type: Investors
url: https://bhtherapeutics.com/investors/
- type: Blog
url: https://bhtherapeutics.com/news/
- type: PressReleases
url: https://bhtherapeutics.com/press-releases/
- type: BlogRSS
url: https://bhtherapeutics.com/feed/
- type: Contact
url: https://bhtherapeutics.com/contact/
- type: Careers
url: https://bhtherapeutics.com/careers/
- type: TermsOfService
url: https://bhtherapeutics.com/terms-of-service/
- type: PrivacyPolicy
url: https://bhtherapeutics.com/privacy-policy/
- type: CookiePolicy
url: https://bhtherapeutics.com/cookie-policy/
- type: LLMsTxt
url: llms/blossomhill-therapeutics-llms.txt
name: llms.txt (published, but every link points at staging)
description: 'Harvested verbatim from https://bhtherapeutics.com/llms.txt (HTTP 200, generated by All in One SEO 4.9.10).
Recorded as-published and unusable as an agent surface: every one of the 33 URLs it advertises — the sitemap, all 13 pages
and all 17 team profiles — points at the Kinsta build/staging host stg-blossomhill-build.kinsta.cloud, which answers HTTP
401 to anonymous requests, rather than at the production host bhtherapeutics.com. Probed 2026-08-07.'
- type: LinkedIn
url: https://www.linkedin.com/company/blossomhill-therapeutics-inc
- type: Twitter
url: https://twitter.com/bhtherapeutics
- type: SecondaryMarket
url: https://forgeglobal.com/blossomhill-therapeutics_stock/
x-enrichment:
date: '2026-08-07'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: BlossomHill is a clinical-stage oncology drug-discovery company with no developer site and no API product; every
OpenAPI, GraphQL, MCP and agent-card path on bhtherapeutics.com returns 404, api./docs./developer.bhtherapeutics.com do
not resolve, and the only machine-readable surface on the domain is the default WordPress /wp-json REST root its marketing
CMS exposes.
evidence:
- url: https://bhtherapeutics.com/openapi.json
status: 404
- url: https://bhtherapeutics.com/.well-known/agent-card.json
status: 404
- url: https://bhtherapeutics.com/graphql
status: 404
- url: https://bhtherapeutics.com/wp-json/
status: 200
- url: https://stg-blossomhill-build.kinsta.cloud/
status: 401
checked: '2026-08-07'
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.